Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease

NCT02740868 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis
Asthma

Interventions

DRUG: Xenon-129 and Perfluoropropane (19F)
DEVICE: Magnetic Resonance Imaging
DEVICE: Lung Clearance Index

Sponsor

The Hospital for Sick Children